Preparing your experience, please wait…
K
Guidelines & protocols
UPDATES ON THE TREATMENT OF DRUG-SUSCEPTIBLE AND DRUG-RESISTANT TUBERCULOSIS
American Thoracic Society, U.S. Centers for Disease Control and Prevention, European Respiratory Society, Infectious Diseases Society of America
PDF202519 pages796 KB
The guidelines were developed by a Joint Panel representing multiple interdisciplinary perspectives, including the American Thoracic Society, CDC, ERS, and IDSA. They focus on the treatment of TB in children and adults, emphasizing the use of mycobacterial cultures, molecular and phenotypic drug susceptibility tests, and radiographic studies. The document aims to adapt existing WHO guidelines to reflect the latest evidence and recommendations for TB treatment.
No account needed
Discuss clinical evidence & guidelines
Examine in Ask OslerAsk this resource
Answers from this document onlyMore like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
GOLD 2026 Pocket Guide to COPD
Same clinical topic · Pulmonology
Guidelines for the Evaluation and Treatment of Pneumonia
Same clinical topic · Pulmonology
GOLD COPD Strategy 2024
Same clinical topic · Pulmonology
National Guidelines for Management of COVID-19, 2nd Edition
Same clinical topic · Pulmonology
Global Strategy for COPD Diagnosis, Management, and Prevention (2026)
Same clinical topic · Pulmonology
COPD-Management-Updates-GOLD-2026
Same clinical topic · Pulmonology
GINA 2024 (2)
Same clinical topic · Pulmonology
DIAGNOSIS AND MANAGEMENT OF COMMUNITY-ACQUIRED PNEUMONIA
Same clinical topic · Pulmonology
TREATMENT OF TUBERCULOSIS
Same clinical topic · Pulmonology